SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
190 hedge funds and large institutions have $3.06B invested in Sage Therapeutics in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 61 increasing their positions, 73 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 189 → 190 (+1)
16% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 73
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
190
Holding in Top 10
4
Calls
$163M
Puts
$138M
Top Buyers
| 1 | +$126M | |
| 2 | +$16.4M | |
| 3 | +$14.3M | |
| 4 |
BlackRock
New York
|
+$13.4M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$7.96M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$21.5M | |
| 3 | -$12.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$9.38M |
| 5 |
DM
Deerfield Management
New York
|
-$8.67M |